Kilitch Drugs Board Meeting on Aug 13 to Approve Unaudited Results

Kilitch Drugs India Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda for this meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. In line with SEBI regulations and the company's code of conduct for preventing insider trading, the trading window has been closed from July 1, 2026, and will reopen 48 hours after the disclosure of these financial results to the stock exchanges.